These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8720549)

  • 1. Moral crisis.
    Long LL
    J Okla State Med Assoc; 1996 Jan; 89(1):5. PubMed ID: 8720549
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acute migraine with sumatriptan--response in 40 consecutive patients.
    Blumenthal HJ; Weisz MA; Burk S
    J Okla State Med Assoc; 1996 Jan; 89(1):7-10. PubMed ID: 8720550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sumatriptan in treatment of migraine and its efficacy and tolerance in self-assessment by patients].
    Prusiński A; Barliński J
    Pol Tyg Lek; 1996 Mar; 51(10-13):187-9. PubMed ID: 8927561
    [No Abstract]   [Full Text] [Related]  

  • 4. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack].
    Stepień A
    Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is subcutaneous sumatriptan an effective treatment for adults presenting to the emergency department with acute migraine headache?
    Jones S; Lang E
    Ann Emerg Med; 2013 Jul; 62(1):11-2. PubMed ID: 23433652
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts of migraine and its treatment.
    Dahlöf CG
    Neurologia; 1999 Feb; 14(2):67-77. PubMed ID: 10100422
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences.
    Cohen JA; Beall DG; Miller DW; Beck A; Pait G; Clements BD
    Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation.
    Laloux P; Vakaet A; Monseu G; Jacquy J; Bourgeois P; van der Linden C
    Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache.
    Kaniecki R; Ruoff G; Smith T; Barrett PS; Ames MH; Byrd S; Kori S
    Curr Med Res Opin; 2006 Aug; 22(8):1535-44. PubMed ID: 16870078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].
    Prusiński A; Król F
    Pol Merkur Lekarski; 1998 Mar; 4(21):158-61. PubMed ID: 9640070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acute migraine with sumatriptan. Clinical experiences with advantages and disadvantages].
    Dahlöf C; Ekbom K; Persson L
    Lakartidningen; 1993 Sep; 90(38):3195-6, 3200. PubMed ID: 8231472
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
    Tepper SJ; Cochran A; Hobbs S; Woessner M
    Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sumatriptan in the treatment of cluster headache and migraine attacks].
    Kolosova OA; Osipova VV; Khomak EB; Bobeĭko LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(5):12-5. PubMed ID: 7900441
    [No Abstract]   [Full Text] [Related]  

  • 20. Pilot study evaluating preference for 3-mg versus 6-mg subcutaneous sumatriptan.
    Landy SH; McGinnis JE; McDonald SA
    Headache; 2005 Apr; 45(4):346-9. PubMed ID: 15836571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.